Table 1.
The basic characteristics of GWAS data.
| Trait | GWAS ID | Consortium | Population | Sample size (case/control) | PMID |
|---|---|---|---|---|---|
| NAFLD | ebi-a-GCST90091033 | eMERGE + UK Biobank + FinnGen + Estonian Biobank | European | 778,614 (8434/770,180) | 34841290 |
| Percent liver fat | ebi-a-GCST90016673 | UK Biobank | European | 32,858 | 34128465 |
| Overweight | ieu-a-93 | Genetic Investigation of ANthropometric Traits (GIANT) | European | 158855 | 23563607 |
| Obesity | finn-b-E4_OBESITYNAS | NA | European | 214677 (4793/209,884) | NA |
| T2DM | ebi-a-GCST006867 | DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) + Genetic Epidemiology Research on Adult Health and Aging (GERA) + UKB | European + Pakistan | 655,666 (61,714/1178) | 30054458 |
| WC | ukb-b-9405 | UKBiobank | European | 462,166 | NA |
| Hypertension | ukb-b-14057 | UKBiobank | European | 462,933 (119,731/343,202) | NA |
| HDL-C | ebi-a-GCST005058 | The United Kingdom Household Longitudinal Study | European | 9796 | 28887542 |
| TG levels | ebi-a-GCST90025957 | UKBiobank | European | 437,532 | 34226706 |
| FBG | ebi-a-GCST005186 | Glucose and Insulin-related traits Consortium (MAGIC) | European | 58,074 | 22581228 |
| IR | ebi-a-GCST005179 | Glucose and Insulin-related traits Consortium (MAGIC) | European | 37,037 | 20081858 |
| LPS | ebi-a-GCST90032674 | FinnDiane, FINRISK and Finnish Twin Cohort | European | 11,296 | 34668383 |
| LBP | ebi-a-GCST90019429 | The Fenland study | European | 10,708 | 33328453 |
FBG = fasting blood glucose, IR = insulin resistance, LBP = lipopolysaccharide-binding protein, LPS = lipopolysaccharide, NAFLD = nonalcoholic fatty liver disease; T2DM = type 2 diabetes, TG = triglyceride levels, WC = waist circumference.